Product Information
PHENOBARBITAL 100 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2357 per EA under NDC 00143145805. Its NADAC has been published 444 times since Nov 28, 2013.
Strength
100 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143145805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
1/7/2000
Price Statistics
The NADAC for PHENOBARBITAL 100 MG TABLET has been published 444 times since Nov 28, 2013, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2357 per EA |
|---|---|
| All-time high | $0.5358 (Jul 14, 2021) |
| All-time low | $0.1832 (Nov 20, 2024) |
| 52-week high | $0.2852 |
| 52-week low | $0.2102 |
| Median price | $0.3272 |
| Average price | $0.3416 |
| Largest weekly change | +50.7% (Dec 20, 2023) |
| Weeks tracked | 444 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 100 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2357 per EA (NDC 00143145805), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 100 MG TABLET has declined 28.0%. It has been tracked across 444 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 100 MG TABLET?
Since Nov 28, 2013, the NADAC for PHENOBARBITAL 100 MG TABLET has ranged from a low of $0.1832 (Nov 20, 2024) to a high of $0.5358 (Jul 14, 2021), with a median of $0.3272 per EA.
Are there cheaper alternatives to PHENOBARBITAL 100 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 100 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 100 MG TABLET?
PHENOBARBITAL 100 MG TABLET (NDC 00143145805) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification